Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 258

Similar articles for PubMed (Select 8622067)

1.

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

Kushner BH, LaQuaglia MP, Wollner N, Meyers PA, Lindsley KL, Ghavimi F, Merchant TE, Boulad F, Cheung NK, Bonilla MA, Crouch G, Kelleher JF Jr, Steinherz PG, Gerald WL.

J Clin Oncol. 1996 May;14(5):1526-31.

PMID:
8622067
2.

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G, et al.

J Clin Oncol. 1995 Nov;13(11):2796-804.

PMID:
7595741
3.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
4.

[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].

Häberle B, Bode U, von Schweinitz D.

Klin Padiatr. 2003 May-Jun;215(3):159-65. German.

PMID:
12778356
7.

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.

Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.

J Clin Oncol. 1996 Oct;14(10):2631-7.

PMID:
8874321
8.

Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.

Stoppa AM, Bouabdallah R, Chabannon C, Novakovitch G, Vey N, Camerlo J, Blaise D, Xerri L, Resbeut M, Di Stefano D, Bardou VJ, Gastaut JA, Maraninchi D.

J Clin Oncol. 1997 May;15(5):1722-9.

PMID:
9164178
9.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569-77.

PMID:
10348286
10.

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

Kushner BH, LaQuaglia MP, Bonilla MA, Lindsley K, Rosenfield N, Yeh S, Eddy J, Gerald WL, Heller G, Cheung NK.

J Clin Oncol. 1994 Dec;12(12):2607-13.

PMID:
7527454
11.

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Arellano-Rodrigo E, López-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F.

Eur J Haematol. 2003 Apr;70(4):219-24.

PMID:
12656744
12.

Desmoplastic small cell tumor: a report of three cases and a review of the literature.

Kretschmar CS, Colbach C, Bhan I, Crombleholme TM.

J Pediatr Hematol Oncol. 1996 Aug;18(3):293-8. Review.

PMID:
8689345
13.

No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.

Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1358-63. doi: 10.1016/j.ijrobp.2008.06.1930. Epub 2008 Nov 18.

PMID:
19019566
14.
15.

VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.

El Weshi A, Memon M, Raja M, Bazarbashi S, Rahal M, El Foudeh M, Pai C, Allam A, El Hassan I, Ezzat A.

Am J Clin Oncol. 2004 Oct;27(5):529-34.

PMID:
15596925
16.

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.

Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.

Ann Oncol. 1997 Jan;8(1):49-56.

17.

Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.

Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC.

J Clin Oncol. 1998 Mar;16(3):937-44.

PMID:
9508176
18.

Desmoplastic small round cell tumour in children and adolescents.

Bisogno G, Roganovich J, Sotti G, Ninfo V, di Montezemolo LC, Donfrancesco A, Mascarin M, Carli M.

Med Pediatr Oncol. 2000 May;34(5):338-42.

PMID:
10797355
19.

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.

Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS.

Ann Oncol. 2002 Mar;13(3):460-9.

20.

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.

Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Lange W, Mertelsmann R.

Ann Oncol. 1999 May;10(5):561-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk